Drug-drug Interaction Study of Omeprazole and Bemnifosbuvir/Ruzasvir

Completed · Phase 1

Conditions studied: Healthy Volunteer Study

In brief

Drug-drug interaction study between Omeprazole and Bemnifosbuvir/Ruzasvir (BEM/RZR)

Key facts

Study ID

NCT07007806

Run by

Atea Pharmaceuticals, Inc.

People needed

20

Starts

2025-05-09

Expected to finish

2025-06-28

Last updated by the study team

2025-08-29

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Must agree to use acceptable contraceptive methods through at least 90 days after the last dose of study drug.
• Minimum body weight of 50 kg and body mass index (BMI) of 18.5-30 kg/m2.
• Willing to comply with the study requirements and to provide written informed consent.

You may not qualify if…

• Infected with hepatitis B virus, hepatitis C virus, HIV or SARS-CoV-2.
• Abuse of alcohol or drugs.
• Use of other investigational drugs within 28 days of dosing.
• Concomitant use of prescription medications, or systemic over-the-counter medications.
• Other clinically significant medical conditions or laboratory abnormalities.

Where it is running

• Atea Study Site — Cypress, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.